NIH Just Opened a $6 Million Kids First Genomic Data Generation Center — and Named the Winner of Its $5 Million Companion RFA

Academic PIs running pediatric genomics cores have until January 8, 2027 to compete for a share of $6 million in first-year funds under RFA-RM-27-008, the Gabriella Miller Kids First Genomic Data Generation Center U24 that NIH posted to Grants.gov on October 29, 2026.

NIH Posted the Whole Kids First Slate in One Day, and Two-Fifths of It Is Already Spoken For

The October 29 listing is not a standalone NOFO. The NIH Common Fund dropped three cooperative-agreement RFAs the same day, all carrying the same January 8, 2027 due date, the same December 8, 2026 package-open date, and the same March 8, 2027 archive date:

That is $12.5 million of first-year money across the slate, and $5 million of it — 40 percent — is not available to you. RFA-RM-27-009 announces the constraint in its own title: "Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)." The synopsis says it "will invite application(s) from the eligible organization(s) to apply" and refers readers to Section III for the names. In NIH drafting convention, that phrasing means the eligible institution is already identified and peer review exists to confirm merit, not to pick a winner.

The incumbent is not a mystery. The Kids First Data Resource Center has been run since 2017 by the Center for Data Driven Discovery in Biomedicine at Children's Hospital of Philadelphia, on an award of up to $14.8 million over five years, with Children's National Hospital, the Ontario Institute for Cancer Research, the University of Chicago, Oregon Health and Science University, and Seven Bridges as partners. The public portal launched in September 2018 with data from roughly 8,000 DNA and RNA samples. The DRC's own site describes the program as funded through 2028.

So read the slate structurally. One piece renews the incumbent. One piece — the $1.5 million Training and Outreach Core, ceiling $900,000 — is a genuinely open but small-dollar foothold. And one piece, the $6 million U24, is the open competition that actually matters.

The Rename From "Genome Sequencing Center" Is the Most Useful Thing in the Posting

NIH forecast this award on May 14, 2025 under notice NOT-RM-25-034, and the forecast title was "Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program." The final RFA is titled "Genomic Data Generation Center." The Grants.gov record is on its third revision, with the change note reading simply "Updated opportunity details to match NOFO."

That is not cosmetic. The 2025 forecast language promised to "fund adding data to the resource, expanding data types as technologies mature and scientific rationale warrant, and expanding to add clinic-based data sources." The final purpose statement spells out what those data types are: the center must support "rapid generation of high quality sequence and variant data (e.g., genome-wide, RNA, and long-read DNA and RNA sequencing, genome-wide methylation profiling, and chromatin accessibility data) from a large number of human specimens representing pediatric conditions, including childhood cancers and congenital anomalies."

Five modalities, named, in the purpose paragraph. Short-read genome-wide sequencing is table stakes. The differentiators are long-read DNA and RNA, genome-wide methylation, and chromatin accessibility — an ATAC-seq or equivalent capability on primary pediatric tumor and affected tissue. If your core runs Illumina at scale and nothing else, you are responsive to the forecast title and not to the RFA.

The other scope signal is the parenthetical plural in the purpose statement: "Center(s)." With $6 million available and a $3.5 million ceiling, NIH has left itself room for either one large center or two mid-sized ones in the $2.5 million to $3.5 million range. If you cannot credibly deliver all five modalities in-house, the arithmetic says a two-institution split is a live outcome and a well-constructed complementary application is not wasted effort. Note also that the forecast estimated $6.6 million; the posted number is $6 million. The haircut is small, but it argues against budgeting to the ceiling without a hard justification.

The Volume Mandate, Not the Science, Is What Reviewers Will Stress-Test

Three phrases in the purpose statement should shape your approach section: "rapid generation," "high quality," and "a large number of human specimens." This is a production award, not a discovery award. It is a U24 — a resource cooperative agreement — and clinical trials are explicitly not allowed. CFDA listing is 93.310, Trans-NIH Research Support, and the funding instrument is a cooperative agreement, meaning substantial NIH programmatic involvement throughout.

The RFA also hands over your downstream dependency in plain terms: "All data generated under this NOFO will be re-processed and harmonized by the Gabriella Miller Kids First Pediatric Data Resource Center (Kids First DRC)." You generate; CHOP harmonizes. Your deliverable is not an analyzed dataset, it is a stream of specimen-level data that lands cleanly in someone else's cloud pipeline on someone else's schedule.

This is where the single-source companion stops being trivia and becomes a writing instruction. Because RFA-RM-27-009 is non-competitive, you know with near certainty which data model, which file formats, which ingestion cadence, and which coordination core you will be interoperating with for the project period. Reviewers will notice the difference between an application that gestures at "data sharing with the DRC" and one that names the Kids First Data Coordination Core, cites the existing harmonization workflows, and commits to specific handoff service levels. The incumbent's continuity is free intelligence. Use it.

The X01 Is Where Your Specimens Come From, and It Is Already Open

The fourth piece of the Kids First architecture is easy to miss because it posted four months earlier and carries no dollar figure. PAR-27-071, "Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)," went up June 18, 2026 and closes January 11, 2027 — three days after the center RFAs.

The X01 awards no funds. It invites investigators "to submit samples from pediatric cohorts for whole genome sequencing at a Kids First Program supported genomic data generating centers," and it accepts proposals for "whole genome, exome, and transcriptome sequencing, as well as clinical-grade sequencing, long-read sequencing, proteomics, and epigenomic assays of tumor or affected tissue, when justified."

That is your order book. The X01 cohort PIs are the demand side; the U24 center is the supply side. For U24 applicants, the practical consequence is that your throughput projections should be anchored to the actual X01 pipeline rather than to your core's nameplate capacity. For cohort-holding PIs who are not building a center, the X01 is the cheaper way into this program — no budget to defend, and sequencing at NIH's expense in exchange for depositing the data into the Kids First resource.

Why the Coordinated-Slate Pattern Keeps Repeating at NIH

Kids First is not an isolated case. NCI ran the same play with its community oncology program, posting three NCORP RFAs totaling $147.5 million as a single 2027 renewal cycle with shared deadlines. NIGMS did something structurally similar when it converted its IDeA-CTR program from a U54 to a P30 and split the result into open and limited-competition tracks.

The pattern is consistent and the lesson is too: when an IC reissues a program as a coordinated set, the set itself encodes who the institute expects to win what. A single-source companion, a conspicuously low-ceiling core, and a staggered feeder mechanism are all public information, posted weeks before anyone writes a specific aims page. Most applicants read one NOFO. The slate tells you more than the NOFO does.

Kids First carries a particular history worth remembering here. The program exists because the Gabriella Miller Kids First Research Act of 2014 terminated public financing for presidential nominating conventions and routed roughly $12.6 million a year for ten years — about $126 million — through the NIH Common Fund for pediatric research. That original authorization has run its course. A $6 million open competition for the data generation anchor, against a $5 million single-source renewal, is what the program's second decade looks like at current scale.

What to Do Before January 8

The application package opens December 8, 2026 and closes January 8, 2027, with a 35-day grace period for error correction and FORMS-I packages required. There is no cost-sharing requirement, no award floor, and foreign institutions are listed among eligible applicants. Program questions go to the Gabriella Miller Kids First Program at kidsfirst@od.nih.gov or 301-402-2541.

Three concrete moves in the next four weeks. First, audit your core against all five named modalities and decide now whether you are applying as a full-scope center or as the complementary half of a two-award split. Second, get the Kids First DRC's current harmonization specifications and write your data handoff plan against them, not around them. Third, if you hold a pediatric cancer or congenital anomaly cohort and are not building a center, pivot to PAR-27-071 and the January 11 date instead.

Next step: Search active NIH pediatric genomics and sequencing-center opportunities on Granted to see the full Kids First slate alongside the other NIH data-resource and genomic-center competitions closing this cycle.